Dr. Gergis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 S Cedar Crest Blvd
Ste 401
Allentown, PA 18103Phone+1 610-402-7880Fax+1 215-955-9641
Education & Training
- Johnson Graduate School of Management of Cornell UniversityMBA, 2015 - 2017
- H. Lee Moffitt Cancer Center and Research InstituteFellowship, Blood & Bone Marrow Transplant, 2006 - 2007
- Brooklyn Hospital CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
- Brooklyn Hospital CenterResidency, Internal Medicine, 2000 - 2003
- Cairo University School of MedicineClass of 1996
- Cornell UniversityNo degree
Certifications & Licensure
- PA State Medical License 2019 - 2024
- NY State Medical License 2007 - 2020
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML) Start of enrollment: 2009 Jun 02
- Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma Start of enrollment: 2009 Apr 23
- Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT) Start of enrollment: 2013 Nov 07
- Join now to see all
Publications & Presentations
PubMed
- Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations ...Mohamed Amine Bekadja, Dietger Niederwiser, Mohamed A Kharfan-Dabaja, Riad El Fakih, Laurent Garderet
Bone Marrow Transplantation. 2024-10-07 - 1 citationsImpact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation.Karen Ballen, Tao Wang, Naya He, Jennifer M Knight, Sanghee Hong
Transplantation and Cellular Therapy. 2024-10-01 - A Tender Reduced-Intensity Conditioning for the Unfit: A Novel 4 Gy Total Body Irradiation-Based Conditioning Followed by Two-Step Haploidentical Stem Cell Transplant,...Xia Bi, Dolores Grosso, Allison Gradone, Joanne Filicko-O'Hara, Kelly A McCorkell
Transplantation and Cellular Therapy. 2024-10-01
Journal Articles
- The Addition Of Low Dose Total Body Irradiation To Fludarabine And Melphalan Conditioning In Haplo-Cord Transplantation For High Risk Hematological MalignanciesChoe HK, Gergis U, Mayer SA, Nagar H, Phillips AA, Shore TB, Smith MJ, van Besien K, Transplantation, 1/19/2016
- Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and survival free of progression and GVHD (GRFS)Van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman ..., Haematologica, 1/11/2016
- Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 InhibitorsShanavas M, Popat U, Michaelis LC, Fauble V, McLornan D, Klisovic R, Mascarenhas J, Tamari R, Arcasoy MO, Davies J, Gergis U, Ukaegbu OC, Kamble RT, Storring JM, Majha..., Biol Blood Marrow Transplant, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF AdministrationUsama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T InfusionUsama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: